Shunsuke Suzuki | medical physics | Best Researcher Award

Mr. ‌ Shunsuke Suzuki| | Thermodynamics | Best Researcher Award

Mr at Shonan Kamakura General Hospital,  Japan

 I am an accomplished researcher and academic, currently pursuing a Ph.D. at the Graduate School of Engineering, Kyoto University. With a strong background in radiation therapy and dosimetry, my research has focused on radiation-induced secondary carcinogenesis and the development of precise γ-ray dosimetry methods for boron neutron capture therapy (BNCT). I have published several papers and presented at numerous conferences, contributing to advancements in proton therapy and BNCT. Currently, I am introducing the “nuBeam” accelerator-based BNCT system at Shonan Kamakura General Hospital and continue to innovate in the field of radiation dosimetry and cancer treatment technologies.



Education, Experience, and Academic Achievements 🎓

I conducted research on radiation-induced secondary carcinogenesis during my master’s course at the Graduate School of Medicine, Hokkaido University, and presented my findings at an academic conference. Following my master’s, I joined the Minami-Tohoku Cancer Proton Therapy Center, where I published a paper on radiation-induced secondary carcinogenesis in children due to different proton therapy irradiation methods. Currently, I work at Shonan Kamakura General Hospital, where I am introducing the accelerator-based boron neutron capture therapy system “nuBeam” and presenting research on its initial evaluation at conferences and in scholarly papers. Additionally, I am conducting research on developing γ-ray dosimetry in neutron fields, which has been published and will be presented at an international conference. I am also pursuing a doctoral degree at the Graduate School of Engineering, Kyoto University, and will graduate this year.

Contributions to Research & Development, Innovations, and Extension Activities 🧪

In the realm of boron neutron capture therapy (BNCT), the radiation emitted by the BNCT machine is directly linked to the patient dose. Therefore, accurately evaluating the gamma ray dose through measurement is crucial for introducing BNCT into clinical practice. Measurement methods for gamma ray doses in BNCT fields currently vary among facilities, necessitating a universally applicable and accurate method. In Japan, a custom-built thermoluminescent dosimeter (TLD) (Panasonic, UD-170LS) with beryllium oxide powder in a quartz glass tube is used for 𝛾 dose measurement, but it is no longer manufactured or commercially available. Consequently, I investigated a method combining a commercially available Mg2SiO4:Tb TLD (TOREC, TLD-MSO-S) with a 6LiF sintered capsule, verifying its efficacy for 𝛾 dose measurement in an accelerator-based (AB)-BNCT system.

Publications Top Notes 📝

  1. Initial evaluation of accelerator-based neutron source system at the Shonan Kamakura General Hospital
    • Authors: S. Suzuki, K. Nitta, T. Yagihashi, P. Eide, H. Koivunoro, N. Sato, S. Gotoh, et al.
    • Journal: Applied Radiation and Isotopes
    • Volume: 199
    • Article: 110898
    • Year: 2023


  1. Effectiveness of robust optimization against geometric uncertainties in TomoHelical planning for prostate cancer
    • Authors: T. Yagihashi, K. Inoue, H. Nagata, M. Yamanaka, A. Yamano, S. Suzuki, et al.
    • Journal: Journal of Applied Clinical Medical Physics
    • Volume: 24
    • Issue: 4
    • Article: e13881
    • Year: 2023


  1. Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients
    • Authors: S. Suzuki, T. Kato, M. Murakami
    • Journal: Journal of Radiation Research
    • Volume: 62
    • Issue: 2
    • Pages: 186-197
    • Year: 2021


  1. Evaluation of dose effects of two types of tomotherapy couch and examination of its optimization
    • Authors: S. Suzuki, T. Inoue, A. Yamano, H. Nagata
    • Journal: Journal of the Korean Physical Society
    • Volume: 83
    • Issue: 12
    • Pages: 984-992
    • Year: 2023


  1. Optimization of TomoTherapy couch density in the RayStation treatment-planning system
    • Authors: S. Suzuki, T. Inoue, T. Yagihashi, H. Nagata
    • Journal: Journal of the Korean Physical Society
    • Volume: 83
    • Issue: 12
    • Pages: 993-1002
    • Year: 2023


  1. Relative Biological Effectiveness Values of Spot-scanning Proton Beam Therapy at Shonan Kamakura General Hospital
    • Authors: S. Shiba, M. Yamanaka, K. Matsumoto, A. Yamano, T. Shimo, S. Suzuki, et al.
    • Journal: in vivo
    • Volume: 37
    • Issue: 3
    • Pages: 1016-1021
    • Year: 2023
    • Abstract: This research investigates the Relative Biological Effectiveness (RBE) values of spot-scanning proton beam therapy at Shonan Kamakura General Hospital. The findings contribute to understanding the biological impact and therapeutic advantages of proton beam therapy in clinical settings.


Yasaman Taslimi | diagnosis | Best Researcher Award

Dr. Yasaman Taslimi | diagnosis| Autonomous systems | Best Researcher Award

Dr, Pasteur institute of Iran, Iran

👩‍🔬 Dedicated researcher with a Ph.D. in Biology from Pasteur Institute of Iran, specializing in molecular genetics and parasitology. 🧬 Skilled in molecular diagnostics and protein analysis for Leishmaniasis. Currently serving as a Researcher in Immunotherapy and Leishmania Vaccine Research at Pasteur Institute, with extensive teaching and visiting researcher experience globally.  Recognized for academic excellence with awards including first rank in Ph.D. studies. Passionate about advancing immunotherapy and infectious disease research, with notable presentations at international congresses and a diverse range of specialized courses attended.🌟






Education 📚

B.Sc. in Nutrition Azad University, Tehran, Iran 2000, M.Sc. in Biochemistry Azad University, Damghan, Iran 2015, PhD in Biology Pasteur Institute of Iran 2023

Position 💼

  • Researcher in Immunotherapy and Leishmania Vaccine Research Department
    Pasteur Institute of Iran

Area of Expertise 🧬

  • Molecular genetics, molecular parasitology, gene function and expression.
  • Molecular diagnosis of Leishmaniasis.
  • Arginase assay.
  • Protein analysis techniques such as Western Blot, Elisa.
  • PEA assay.
  • LAMP assay.

Courses 🎓

Molecular DATA for infectious disease, ITM, Antwerp, Belgium, 2018International Workshop of Leishmania and Leishmaniasis, Pasteur Iran, 2016Molecular Biology of Leishmaniasis, ICGEB, Trieste, Italy, 2016.Targeting and Expression of Gene in Cells, International Congress of Immunology, Tehran, 2014How to write an International Article, Elsevier workshop, Tehran, 2014Application of Bioinformatics in Biotechnology, Pasteur Iran, 2013Flow Cytometry workshop, Pasteur Iran, 2012Quality Control Management, Pasteur Iran, 2012Calibration methods and standards, Pasteur Iran, 2011Life skills courses (Depression, Anger management, Time management, …), Pasteur, 2010Advanced Molecular Genetic course, Pasteur Iran, 2006ICDL courses, 2006

Teaching 📝

High throughput technologies in translational immunology, Pasteur, Iran, 2022Western Blot, Practical, School of Pharmacy, Shahid Beheshti University, Tehran, Iran, 2016Immunology of infectious disease, Practical, Pasteur Iran, 2006

Visiting Researcher 🌍

Gothenburg University (Leishild-MATI RISE project), Department of Microbiology and Immunology at Institute of Biomedicine, 2019/02/26-2019/05/14Pasteur Institute of Paris (Leishild-MATI RISE project), Department of Molecular Parasitology and Signaling, 2023/12/17-2023/02/17

Congress Presentations 🗣️

International Congress of Dermatology, Cosmetics and Laser, Iran, Tehran, 2022.International congress of immunology, Iran, Ahvaz, 2021.The 17th International Congress of Immunology, Beijing, China, 2019.Molecular Biology of Leishmania course, Trieste, Italy, 2016.Annual Symposium of the Institut Pasteur International Network, Paris, 2015.6th Worldleish international congress, Toledo, Spain, 2017.

Awards 🏆

The Second National Conference on New Cellular and Molecular, Iran, 2015.13th International Congress of Immunology and Allergy of Iran, Tabriz, 2015.First ranked Ph.D. student in Pasteur Institute of Iran, 2018.

Publications Top Notes 📝

  1. Title: Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis
    Authors: A Zadeh-Vakili, T Taheri, Y Taslimi, F Doustdari, AH Salmanian, S Rafati
    Journal: Vaccine
    Volume: 22
    Issue: 15-16
    Pages: 1930-1940
    Year: 2004
    Citations: 81


  1. Title: Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen
    Authors: F Zahedifard, E Gholami, T Taheri, Y Taslimi, F Doustdari, N Seyed, …
    Journal: PLoS neglected tropical diseases
    Volume: 8
    Issue: 3
    Pages: e2751
    Year: 2014
    Citations: 79


  1. Title: Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis
    Authors: N Saljoughian, T Taheri, F Zahedifard, Y Taslimi, F Doustdari, …
    Journal: PLoS neglected tropical diseases
    Volume: 7
    Issue: 4
    Pages: e2174
    Year: 2013
    Citations: 75


  1. Title: Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral …
    Authors: S Rafati, E Gholami, N Hassani, F Ghaemimanesh, Y Taslimi, T Taheri, …
    Journal: Vaccine
    Volume: 25
    Issue: 21
    Pages: 4159-4169
    Year: 2007
    Citations: 71


  1. Title: Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals
    Authors: N Khoshgoo, F Zahedifard, H Azizi, Y Taslimi, MJ Alonso, S Rafati
    Journal: Vaccine
    Volume: 26
    Issue: 46
    Pages: 5822-5829
    Year: 2008
    Citations: 61